AKT1 and central nervous system cancer: For instance, glioma cells transfer oncogenic EGFR variant III (EGFRvIII) via EVs to other glioma cells lacking this receptor, promoting their morphological transformation and cell proliferation by activating the MAPK and AKT signaling pathway.93